Engineering Herpes Simplex

Advances in Pharmacology

Volumn 40, Issue C, 1997, Pages

  Glorioso, Joseph C ^a   Goins, William F ^a   Schmidt, Martin C ^a   Oligino, Thomas ^a   Krisky, David M ^a   Marconi, Peggy C ^a   Cavalcoli, James D ^a   Ramakrishnan, Ramesh ^a   Poliani, P Luigi ^a   Fink, David J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; GENE THERAPY; GENE VECTOR; GENETIC ENGINEERING; GENETICS; HERPES SIMPLEX VIRUS; HUMAN; REVIEW;

ANIMALS; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; SIMPLEXVIRUS;

EID: 77956776542     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60139-8     Document Type: Article

References (163)

1. Acsadi G., Dickson G., Love D., Jani A., Walsh F., Gurusinghe A., Wolff J., and Davies K. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature (London) 352 (1991) 815-818
2. Acsadi G., Jani A., Massie B., Simoneau M., Holland P., Blaschuk K., and Karpati G. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet. 3 (1994) 579-584
3. Adler R., Glorioso J.C., Cossman J., and Levine M. Possible role of Fc receptors on cells infected and transformed by herpesvirus: Escape from immune cytolysis. Infect. Immun. 21 (1978) 442-447
4. Akli S., Cailland C., Vigne E., Stratford-Perricaudet L., Poenaru L., Perricaudet M., and Peschanski M. Transfer of a foreign gene into the brain using adenovirus vectors. Nat. Genet. 3 (1993) 224-228
5. Arahata K., Ishiura S., Ishiguro T., Tsukahara T., Suhara Y., Eguchi C., Ishiara T., Nonaka I., Ozawa E., and Sugita H. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature (London) 333 (1988) 861-863
6. Bak I.J., Markhan C.H., and Cook M.L. Intra-axonal transport of herpes simplex virus in the rat central nervous system. Brain Res. 136 (1977) 415-429
7. Battleman D., Geller A., and Chao M. HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding. J. Neurosci. 13 (1993) 941-951
8. Bloom D., Hill J., Devi-Rao G., Wagner E., Feldman L., and Stevens J. A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J. Virol. 70 (1996) 2449-2459
9. Boviatsis E., Chase M., Wei M., Tamiya T., Hurford R., Kowall N., Tepper R., Breakefield X., and Chiocca E. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. Hum. Gene Ther. 5 (1994) 183-191
10. Brown C.R., Nakamura M.S., Mosca J.D., Hayward G.S., Straus S.T., and Perera L.P. Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3 ends of labile mRNA. J. Virol. 69 (1995) 7187-7195
11. Cai W., Person S., Warner S., Zhou J., and Glorioso J. Linker-insertion nonsense and restriction-site deletion mutations of the gB glycoprotein gene of herpes simplex virus type 1. J. Virol. 61 (1987) 714-721
12. Cai W., Gu B., and Person S. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol. 62 (1988) 2596-2604
13. Campadelli G., Brandimarti R., Lazzaro C.D., Ward P., Roizman B., and Torrisi M. Fragmentation and dispersal of Golgi proteins and redistribution of glycoproteins and glycolipids processed through Golgi following infection with herpes simplex virus 1. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 2798-2802
14. Carey M., Leatherwood J., and Ptashne M. A potent GAL4 derivative activates transcription at a distance in vitro. Science 247 (1990) 710-712
15. Casaccia-Bonnefil P., Benedikz E., Shen H., Stelzer A., Edelstein D., Geschwind M., Brownlee M., Federoff H.J., and Bergold P.J. Localized gene transfer into organotypic hippocampal slice cultures and acute hippocampal slices. J. Neurosci. Methods 50 (1993) 341-351
16. Challberg M. A method of identifying the viral genes required for herpesvirus DNA replication. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 9094-9098
17. Chamber R., Gillespie G.Y., Soroceanu L., Andreansky S., Chatterjee S., Chou J., Roizman B., and Whitley R. Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 1411-1415
18. Chasman D.I., Leatherwood M., Carey M., Ptashne M., and Romberg R.D. Activation of yeast polymerase II transcription by herpesvirus VP16 and GAL4 derivative in vitro. Mol. Cell. Biol. 9 (1989) 4746-4749
19. Chen X., Schmidt M.C., Goins W.F., Hendricks R.L., Fink D., and Glorioso J.C. HSV-1 Vector-mediated lacZ gene transfer to the nervous system: Long term gene expression using the viral latency-active promoter. Gene Ther. (1996) (submitted for publication)
20. Chou J., and Roizman B. The γ 34.5 gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff protein synthesis characteristic of programmed cell death in neuronal cells. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 3266-3270
21. 1 34.5 gene function which blocks the host response to infection maps in the homologous domain of the genes expressed during growth arrest and DNA damage. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 5247-5251
22. Coen D.M., Kosz-Venchak M., Jacobson J.G., Leib D.A., Bogard C.L., Schaffer P.A., Tyler K.L., and Knipe D.M. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 4736-4740
23. Croen K.D., Ostrove J.M., Dragovic L.J., Smialek J.E., and Straus S.E. Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization. N. Engl. J. Med. 317 (1987) 1427-1432
24. Danko I., Fritz J., Latendresse J., Herweijer H., Schultz E., and Wolff J. Dystrophin expression improves myofiber survival in mdx muscles following intramuscular plasmid DNA injection. Hum. Mol. Genet. 2 (1993) 2055-2061
25. Davidson G., Allen E., Kozarsky K.F., Wilson J., and Roessler B. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat. Genet. 3 (1993) 219-223
26. Davison A., and Wilkie N. Inversion of the two segments of the herpes simplex virus genome in intertypic recombinants. J. Gen. Virol. 64 (1983) 1-18
27. Deatly A.M., Spivack J.G., Lavi E., O'Boyle D., and Fraser N.W. Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome. J. Virol. 62 (1988) 749-756
28. Deiss L., Chou J., and Frenkel N. Functional domain within the "a" sequence involved in the cleavage-packaging of herpes simplex virus DNA. J. Virol. 57 (1986) 605-618
29. DeLuca N.A., and Schaffer P.A. Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4. Mol. Cell. Biol. 5 (1985) 1997-2008
30. DeLuca N.A., McCarthy A.M., and Schaffer P.A. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 56 (1985) 558-570
31. Desai P., Schaffer P., and Minson A. Excretion of noninfectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes-simplex virus type 1: Evidence that gH is essential for virion infectivity. J. Gen. Virol. 69 (1988) 1147-1156
32. Desai P., Ramakrishnan R., Lin Z.W., Ozak B., Glorioso J.C., and Levine M. The RR1 gene of herpes simplex virus type 1 is uniquely transactivated by ICP0 during infection. J. Virol. 67 (1993) 6125-6135
33. Devi-Rao G.B., Goddart S.A., Hecht L.M., Rochford R., Rice M.K., and Wagner E.K. Relationship between polyadenylated and nonpolyadenylated HSV type 1 latency-associated transcripts. J. Gen. Virol. 65 (1991) 2179-2190
34. de Waal-Malefyt R., Haanen J., and Spits H. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J. Exp. Med. 174 (1991) 915-924
35. Dixon R.A.F., and Schaffer P.A. Fine-structuring mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP175. J. Virol. 36 (1980) 189-203
36. Dobson A.T., Sederati F., Devi Rao G., Flanagan W.M., Farrell M.J., Stevens J.G., Wagner E.K., and Feldman L.T. Identification of the latency-associated transcript promoter by expression of rabbit β-globin mRNA in the mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J. Virol. 63 (1989) 3844-3851
37. Doerig C., Pizer L.I., and Wilcox C.L. An antigen encoded by the latency-associated transcripts in neuronal cell cultures latently infected with herpes simplex virus type 1. J. Virol. 65 (1991) 2724-2727
38. Dunckley M., Love D., Davies K., Walsh F., Morris G., and Discon G. Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro. FEBS Lett. 2 (1992) 128-134
39. During M., Naegele J., O'Malley K., and Geller A. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266 (1994) 1399-1403
40. Emi N., Friedmann T., and Yee J. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J. Virol. 65 (1991) 1202-1207
41. Everett R., and Maul G. HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J. 13 (1994) 5062-5069
42. Everett R.D. The regulation of transcription of viral and cellular genes by herpesvirus immediate-early gene products. Anticancer Res. 7 (1987) 589-604
43. Fareed M., and Spivack J. Two open reading frames (ORF1 and ORF2) within the 2.0-kilobase latency-associated transcript of herpes simplex virus type 1 are not essential for reactivation from latency. J. Virol. 68 (1994) 8071-8081
44. Farrell M.J., Dobson A.T., and Feldman L.T. Herpes simplex virus latency-associated transcript is a stable intron. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 790-794
45. Fink D.J., Sternberg L.R., Weber P.C., Mata M., Goins W.F., and Glorioso J.C. In vivo expression of β-galactoside in hippocampal neurons by HSV-mediated gene transfer. Hum. Gene Ther. 3 (1992) 11-19
46. Frenkel N., Locker H., Batterson W., Hayward G., and Roizman B. Anatomy of herpes simplex DNA. VI. Defective DNA originates from the S component. J. Virol. 20 (1976) 527-531
47. Furlong D., Swift H., and Roizman B. Arrangement of herpesvirus deoxyribonucleic acid in the core. J. Virol. 10 (1972) 1071-1074
48. Furth P., Hennighausen L., Baker C., Beatty B., and Woychick R. The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice. Nucleic Acids Res. 19 (1991) 6205-6208
49. Geller A., and Breakefield X. A defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons. Science 241 (1988) 1667-1669
50. Geller A., and Freese A. Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli β-galactosidase. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 1149-1153
51. Geller A., During M., Haycock J., Freese A., and Neve R. Long-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a herpes simplex virus type 1 vector. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 7603-7607
52. Gerster T., and Roeder R. A herpesvirus transactivating protein interacts with transcription factor OTF-1 and other cellular proteins. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 6347-6351
53. Geschwind M., Kessler J., Geller A., and Federoff H. Transfer of the nerve growth factor gene into cell lines and cultured neurons using a defective herpes simplex virus vector. Transfer to the NGF gene into cells by a HSV-1 vector. Brain Res. 24 (1994) 327-335
54. Gibson W., and Roizman B. Compartmentalization of spermine and spermidine in the herpes simplex virion. Proc. Natl. Acad. Sci. U.S.A. 68 (1971) 2818-2821
55. L flanking repeats. J. Virol. 68 (1994) 2239-2252
56. Gordon Y.J., Johnson B., Romanonski E., and Araullo-Cruz T. RNA complementary to herpes simplex virus type 1 ICPO gene demonstrated in neurons of human trigeminal ganglia. J. Virol. 62 (1988) 1832-1835
57. 1 34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells. J. Virol. 70 (1996) 84-90
58. Herold B., Wudunn D., Soltys N., and Spear P. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65 (1991) 1090-1098
59. Herold B., Visalli R., Susmarski N., Brandt C., and Spear P. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface herparan sulfate and glycoprotein B. J. Gen. Virol. 74 (1994) 1211-1222
60. Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., Ploegh H., and Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature (London) 375 (1995) 411-415
61. Hill J.M., Sedarati F., Javier R.T., Wagner E.K., and Stevens J.G. Herpes simplex virus latent phase transcription facilitiates in vivo reactivation. Virology 174 (1990) 117-125
62. Ho D., Mocarski E., and Sapolsky R. Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 3655-3659
63. Ho D.Y., and Mocarski E.S. Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 7596-7600
64. Hoffer B.A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L.-F., and Gerhard G. GDNF reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182 (1995) 107-111
65. Hoffman E., Brown R., and Kunkel L. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell (Cambridge, Mass.) 51 (1987) 919-928
66. Holland L.E., Anderson K.P., Shipman C., and Wagner E.K. Viral DNA synthesis is required for efficient expression of specific herpes simplex virus type 1 mRNA. Virology 101 (1980) 10-24
67. Honess R., and Roizman B. Regulation of herpes simplex virus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14 (1974) 8-19
68. Hsu D., de Waal Malefyt R., and Fiorentino D. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250 (1990) 830-832
69. Huard J., Acsadi G., Jani A., Massie B., and Karpati G. Gene transfer into skeletal muscles by isogenic myoblasts. Hum. Gene Ther. 5 (1994) 949-958
70. Huard J., Lochmuller H., Acsadi G., Jani A., Holland P., Guérin C., Massie B., and Karpati G. Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants. Exp. Med. Pathol. 62 (1995) 131-143
71. Huard J., Akkaraju G., Watkins S.C., Pike-Cavalcoli M., and Glorioso J.C. LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector. Hum. Gene Ther. 8 (1997) 439-452
72. Hung S., Srinivasan S., Friedman H., Eisenberg R., and Cohen G. Structural basis of C3b binding by glycoprotein C of herpes simplex virus. J. Virol. 66 (1992) 4013-4027
73. Hung S., Peng C., Kostavasili I., Friedman H., Lambrid J., Eisenberg R., and Cohen G. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway. Virology 203 (1994) 299-312
74. Hutchinson L., and Johnson D. Herpes simplex virus glycoprotein K promotes egress of virus particles. J. Virol. 69 (1995) 5401-5413
75. Hutchinson L., Browne H., Wargent V., Davis-Poynter N., Primorac S., Goldsmith K., Minson A., and Johnson D. A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J. Virol. 6 (1992) 2240-2250
76. Jacob R., Morse L., and Roizman B. Anatomy of herpes simplex virus DNA. XII. Accumulation of head-to-tail concatemers in nuclei of infected cells and their role in the generation of the four isomeric arrangements of viral DNA. J. Virol. 29 (1979) 448-457
77. Jacobson J., Leib D., Goldstein D., Bogard C., Schaffer P., Weller S., and Cohen D. A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive, acute, and reactivatible infections for mice and for replication in mouse cells. Virology 173 (1989) 276-283
78. Javier R.T., Stevens J.G., Dissette V.B., and Wagner E.K. A herpes simplex virus transcript abundant in latently infected neurons is dispensible for establishment of the latent state. Virology 166 (1988) 254-257
79. Johnson A.C., Jinno Y., and Merlino G.T. Modulation of epidermal growth factor receptor proto-oncogene transcription by a promoter site sensitive to S1 nuclease. Mol. Cell. Biol. 8 (1988) 4174-4184
80. Johnson D., and Spear P. Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells. J. Virol. 43 (1982) 1102-1112
81. Johnson D., Burke R., and Gregory T. Soluble forms of herpes simplex virus glycoprotein D bind to limited number of cell surface receptors and inhibit virus entry into cells. J. Virol. 64 (1990) 2569-2576
82. Johnson P., Miyanohara A., Levine F., Cahill T., and Friedmann T. Cytotoxicity of a replication-defective mutant herpes simplex virus type 1. J. Virol. 66 (1992) 2952-2965
83. Johnson P., Wang M., and Friedman T. Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function. J. Virol. 68 (1994) 6347-6362
84. Kaplitt M., Kwong A., Kleopoulos S., Mobbs C., Rabkin S., and Pfaff D. Preproen-kephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8979-8983
85. Kaplitt M., Leone P., Samulski R., Xiao X., Pfaff D., O'Malley K., and During M. Long-term gene expression and phenotype correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8 (1994) 148-154
86. Karpati G., and Acsadi G. The principles of gene therapy in Duchenne muscular dystrophy. Clin. Invest. Med. 17 (1994) 531-541
87. Kasahara N., Dozy M., and Kan W.W. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266 (1994) 1373-1376
88. Katan M., Haigh A., Verrijzer C., van der Vliet P., and O'Hare P. Characterization of a cellular factor which interacts functionally with Oct-1 in the assembly of a multicomponent transcription complex. Nucleic Acids Res. 18 (1990) 6871-6880
89. Kearns C., and Gash D. GDNF protects nigral dopamine neurons against 6-hydroxydo-pamine in vivo. Brain Res. 672 (1995) 104-111
90. Koedood M., Fichtel A., Meier P., and Mitchell P. Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. J. Virol. 69 (1995) 2194-2207
91. Kosz-Vnenchak M., Coen D., and Knipe D. Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses. J. Virol. 64 (1990) 5396-5402
92. Kristie T., and Sharp P. Purification of the cellular C1 factor required for the stable recognition of the Oct-1 homeodomain by herpes simplex virus α-trans-induction factor (VP16). J. Biol. Chem. 268 (1993) 6525-6534
93. Kwong A.D., Kruper J.A., and Frenkel N. Herpes simplex virus virion host shutoff function. J. Virol. 62 (1988) 912-921
94. Le Gal La Salle G., Robert J., Berrard S., Ridoux V., Stratford-Perricaudet L., Perricaudet M., and Mallet J. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259 (1993) 988-990
95. Lehner T., Wilton J., and Shillitoe E. Immunological basis for latency, recurrences, and putative oncogenicity of herpes simplex virus. Lancet 2 (1975) 60-62
96. Leib D.A., Nadeau K.C., Rundle S.A., and Schaffer P.A. Promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: Role of the latency-associated transcripts and cAMP in reactivation of viral latency. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 48-52
97. Leiden J., Frenkel N., and Rapp F. Identification of the herpes simplex virus DNA sequences present in six herpes simplex virus thymidine kinase-transformed mouse cell lines. J. Virol. 33 (1980) 272-285
98. Ligas M., and Johnson D. A herpes simplex virus mutant in which glycoprotein D sequences are replaced by β-galactosidase sequences binds to but is unable to penetrate into cells. J. Virol. 62 (1988) 1486-1494
99. Lokensgard J.R., Bloom D.C., Dobson A.T., and Feldman L.T. Long-term promoter activity during herpes simplex virus latency. J. Virol. 68 (1994) 7148-7158
100. MacLean A., uI-Fareed M., Robertson L., Harland J., and Brown S. Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in GIasgow strain 17+ between immediate early gene 1 and the "a" sequence. J. Gen. Virol. 72 (1991) 631-639
101. Margolis T.P., Bloom D.C., Dobson A.T., Feldman L.T., and Stevens J.G. Decreased reporter gene expression during latent infection with HSV LAT promoter constructs. Virology 197 (1993) 585-592
102. Markert J., Malick A., Coen D., and Martuza R. Reduction of elimination of encephalitis in experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir. Neurosurgery 32 (1993) 597-603
103. Martuza R., Malick A., Markert J., Ruffner K., and Coen D. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252 (1991) 854-856
104. Maul G., and Everett R. The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICPO. J. Gen. Virol. 75 (1994) 1223-1233
105. 2 genes by viral DNA replication. Virology 161 (1967) 593-598
106. McFarland D.J., Sikora E., and Hotchkin J. The production of focal herpes encephalitis in mice by stereotaxic inoculation of virus. Anatomical and behavioral effects. J. Neurol. Sci. 72 (1986) 307-318
107. McGregor F., Phelan A., Dunlop J., and Clements J. Regulation of herpes simplex virus poly(A) site usage and the action of immediate-early protein IE63 in the early-late switch. J. Virol. 70 (1996) 1931-1940
108. Mineta T., Rabkin S., and Martuza R. Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant. Cancer Res. 54 (1994) 3963-3966
109. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248 (1994) 1230-1234
110. Morgan J., Pagel C., Sherrat T., and Partridge T. Long-term persistence and migration of myogenic cells injected into preirradiated muscles of mdx mice. J. Neurol. Sci. 115 (1993) 191-200
111. Navarro D., Paz P., and Pereira L. Domains of herpes simplex virus 1 glycoprotein B that function in virus penetration, cell-to-cell spread, and cell fusion. Virology 186 (1992) 99-112
112. Newcomb W., and Brown J. Induced extrusion of DNA from the capsid of herpes simplex virus type 1. J. Virol. 68 (1994) 433-440
113. O'Hare P., and Goding C. Herpes simplex virus regulatory elements and the immunoglobulin octamer domain bind a common factor and are both targets for virion transactivation. Cell (Cambridge, Mass.) 52 (1988) 435-445
114. Oligino T., Poliani P.L., Marconi P., Bender M.A., Schmidt M.C., Fink D.J., and Glorioso J.C. In vivo transgene activation from an HSV-based gene vector by GAL4:VP16. Gene Ther. 3 (1996) 892-899
115. Oroskar A., and Read G. Control of mRNA stability by the virion host shutoff function of herpes simplex virus. J. Virol. 63 (1989) 1897-1906
116. Perng G.-C., Chokephaibulkit K., Thompson R., Sawtell N., Slanina S., Ghiasi H., Nesburn A., and Wechsler S. The region of the herpes simplex virus type 1 LAT gene that is colinear with the ICP34.5 gene is not involved in spontaneous reactivation. J. Virol. 70 (1996) 282-291
117. Preston C. Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK. J. Virol. 29 (1979) 275-284
118. Preston C., Frame M., and Campbell M. A complex formed between cell components and an HSV structural polypeptide binds to a viral immediate early gene regulatory DNA sequence. Cell (Cambridge, Mass.) 52 (1988) 425-434
119. Quantin B., Perricaudet L., Tajbakhsh S., and Mandel J.-L. Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 2581-2584
120. Ragot T., Vincent N., Chafey P., Gilgenkrantz H., Couton D., Cartaud J., Briand P., Kaplan J.-C., Perricaudet M., and Kahn A. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature (London) 324 (1993) 647-650
121. Ramakrishnan R., Fink D.J., Guihua J., Desai P., Glorioso J.C., and Levine M. Competitive quantitative polymerase chain reaction (PCR) analysis of herpes simplex virus type 1 DNA and LAT RNA in latently infected cells of the rat brain. J. Virol. 68 (1994) 1864-1870
122. Ramakrishnan R., Levine M., and Fink D. PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant. J. Virol. 68 (1994) 7083-7091
123. Read G.S., and Frenkel N. Herpes simplex virus mutants defective in the virion associated shutoff of host polypeptide synthesis and exhibiting abnormal synthesis of α (immediate early) viral polypeptides. J. Virol. 46 (1983) 498-512
124. Rice S., Long M., Lam V., and Spencer C. RNA polymerase II is aberrantly phosphorylated and localized to viral replication compartments following herpes simplex virus infection. J. Virol. 68 (1994) 988-1001
125. Rock D.L., Nesburn A.B., Ghiasi H., Ong J., Lewis T.L., Lokensgard J.R., and Wechsler S. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J. Virol. 61 (1987) 3820-3826
126. Roizman B., and Furlong D. The replication of herpesviruses. In: Fraenkel-Conrat H., and Wagner R.R. (Eds). Comprehensive Virology (1974), Plenum, New York 229-403
127. Roop C., Hutchinson L., and Johnson D. A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. J. Virol. 67 (1993) 2285-2297
128. Russell J., Stow E., Stow N., and Preston C. Abnormal forms of the herpes simplex virus immediate early polypeptide Vmw175 induce the cellular stress response. J. Gen. Virol. 68 (1987) 2397-2406
129. Sacks W., Greene C., Aschman D., and Schaffer P. Herpes simplex virus type 1 ICP27 is essential regulatory protein. J. Virol. 55 (1985) 796-805
130. Sadowski I., Ma J., Triezenberg S., and Ptashne M. GAL4/VP16 is an unusually potent transcriptional activator. Nature (London) 335 (1988) 563-564
131. Salvatori G., Ferrari G., Messogiorno A., Servidei A., Coletta M., Tonali P., Giavazzi R., Cossu G., and Mavilio F. Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo. Hum. Gene Ther. 4 (1993) 713-723
132. Samaniego L., Webb A., and DeLuca N. Functional interaction between herpes simplex virus immediate-early proteins during infection: Gene expression as a consequence of ICP27 and different domains of ICP4. J. Virol. 69 (1995) 5705-5715
133. Sandri-Goldin R., and Hibbard M. The herpes simplex virus type 1 regulatory protein ICP27 coimmunoprecipitates with anti-sm antiserum, and the C terminus appears to be required for this interaction. J. Virol. 70 (1996) 108-118
134. Sandri-Goldin R., Hibbard M., and Hardwicke M. The C-terminal repressor region of herpes simplex virus type 1 ICP27 is required for the redistribution of small nuclear ribonucleoprotein particles and splicing factor SC25; however, these alterations are not sufficient to inhibit host cell splicing. J. Virol. 69 (1995) 6063-6076
135. Sauer B., Whealy M., Robbins A., and Enquist L. Site-specific insertion of DNA into a pseudorabies virus vector. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 3160-3167
136. Sawtell N.M., and Thompson R.L. Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J. Virol. 66 (1992) 2157-2169
137. Schmidt E., Christoph G., Zeller R., and Leder P. The cytomegalovirus enhancer: A pan-active control element in transgenic mice. Mol. Cell. Biol. 10 (1990) 4406-4411
138. Sedarati F., Izumi K.M., Wagner E.K., and Stevens J.G. Herpes simplex virus type 1 latency-associated transcript plays no role in establishment or maintenance of a latent infection in murine sensory neurons. J. Virol. 63 (1989) 4455-4458
139. Shieh M.-T., and Spear P. Herpes virus-induced cell fusion that is dependent on cell surface heparan sulfate on soluble heparin. J. Virol. 68 (1994) 1224-1228
140. Skaliter R., Makhov A., Griffith J., and Lehman I. Rolling circle DNA replication by extracts of herpes simplex virus type 1-infected human cells. J. Virol. 70 (1996) 1132-1136
141. Smith I.L., Hardwicke M.A., and Sandri-Goldin R.M. Evidence that the herpes simplex virus immediate early protein ICP27 acts posttranscriptionally during infection to regulate gene expression. Virology 186 (1992) 74-86
142. Spaete R., and Frenkel N. The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning amplifying vector. Cell (Cambridge, Mass.) 30 (1982) 295-304
143. Spear P. Membrane fusion induced by herpes simplex virus. In: Bentz J. (Ed). Viral Fusion Mechanisms (1993), CRC Press, Boca Raton, Florida. 201-232
144. Spivack J., and Fraser N. Expression of herpes simplex virus type 1 latency-associated transcripts in trigeminal ganglia of mice during acute infection and reactivation of latent infection. J. Virol. 62 (1988) 1479-1485
145. Spivack J.G., and Fraser N.W. Detection of herpes simplex virus type 1 transcripts during latent infection in mice. J. Virol. 61 (1987) 3841-3847
146. Spivack J.G., Woods G.M., and Fraser N.W. Identification of a novel latency-specific splice donor signal within HSV type 1 2.0-kilobase latency-associated transcript (LAT): Translation inhibition of LAT open reading frames by the intron within the 2.0-kilobase LAT. J. Virol. 65 (1991) 6800-6810
147. Steiner I., Spivack J.G., Lirette R.P., Brown S.M., MacLean A.R., Subak-Sharpe J., and Fraser N.W. Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J. 8 (1989) 505-511
148. Stevens J.G., Wagner E.K., Devi-Rao G.B., Cook M.L., and Feldman L.T. RNA complementary to a herpesvirus a gene mRNA is prominent in latently infected neurons. Science 255 (1987) 1056-1059
149. Stinski M.F., and Roehr T.J. Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components. J. Virol. 55 (1985) 431-441
150. Thomsen D.R., Sternberg R.M., Goins W.F., and Stinski M.F. Promoter regulatory region of the major immediate early gene of human cytomegalovirus. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 659-663
151. Tomac A., Linquist E., Lin L.-F., Ogren S., Young D., Hoffer B., and Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature (London) 373 (1995) 335-339
152. Vieira P., Waal-Malefty R.D., and Dang M. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 1172-1176
153. Vincent N., Ragot T., Gilgenkrantz H., Couton D., Chafey P., Grégoire A., Briand P., Kaplan J.-C., Kahn A., and Perricaudet M. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat. Genet. 5 (1993) 130-134
154. Wagner E.K., Devi-Rao G., Feldman L.T., Dobson A.T., Zhang Y., Elanagan W.F., and Stevens T. Physical characterization of the herpes simplex virus latency-associated transcript in neurons. J. Virol. 63 (1988) 1194-2002
155. Watson R., and Clements J. A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis. Nature (London) 285 (1980) 329-330
156. Werstuck G., and Capone J. An unusual cellular factor potentiates protein-DNA complex assembly Oct-1 and Vmw65. J. Biol. Chem. 268 (1993) 1272-1278
157. 1 34.5 deletion mutants in rodent models. J. Clin. Invest. 91 (1993) 2837-2843
158. Wilson A., LaMarco K., Peterson M., and Herr W. The VP16 accessory protein HCF is a family of polypeptides processed from a large precursor protein. Cell (Cambridge, Mass.) 74 (1993) 115-125
159. Wudunn D., and Spear P. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63 (1989) 52-58
160. Yamada Y., Kimura H., Morishima T., Daikoku T., Maeno K., and Nishiyama K. The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice. J. Infect. Dis. 164 (1991) 1091-1097
161. Yang Y., Nunes F., Berencis K., Gonczol E., Engelhardt J., and Wilson J. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Genet. 7 (1994) 362-369
162. York I., Roo C., Andrews D., Riddell S., Graham F., and Johnson D. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell (Cambridge Mass.) 77 (1994) 525-535
163. Zubrzycka-Gaarn E.E., Bulman D.E., Karpati G., Burghes A.H., Belfall B., Klamut H.J., Talbot J., Hodges R.S., Ray P.N., and Worton R.G. The Duchenne muscular dystrophy gene is localized in the sarcolemma of human skeletal muscle. Nature (London) 333 (1988) 466-469